Vertex Pharmaceuticals Incorporated (VRTX)

Last Closing Price: 436.00 (2025-05-23)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

Vertex Pharmaceuticals Incorporated (VRTX) had Earnings per Share (EPS) (Diluted) of $2.49 for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$2.77B
$646.30M
$363.00M
$2.41B
$2.14B
$630.10M
$100.30M
$730.40M
$730.40M
$646.30M
$646.30M
$646.30M
$646.30M
$630.10M
$678.50M
256.90M
259.50M
$2.52
Earnings per Share (EPS) (Diluted)
$2.49
Balance Sheet Financials
$10.01B
$1.30B
$12.87B
$22.88B
$3.78B
$111.40M
$2.60B
$6.38B
$16.50B
$14.97B
$16.50B
256.97M
Cash Flow Statement Financials
$818.90M
$-55.80M
$-680.40M
$4.57B
$4.69B
$113.20M
$166.10M
--
--
Fundamental Metrics & Ratios
2.65
--
--
0.01
0.01
86.90%
22.75%
22.75%
--
26.37%
23.33%
$778.20M
--
--
--
0.12
0.27
1.53
58.65
3.92%
4.32%
2.82%
3.89%
$64.20
$3.00
$3.16